Qi Liao
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 31
- MicroRNA in disease regulation 7
- Molecular Biology top 5%
- RNA modifications and cancer 21
- RNA Research and Splicing 13
- RNA and protein synthesis mechanisms 10
- Epigenetics and DNA Methylation 8
- vaccines and immunoinformatics approaches 4
- Endocrinology top 5%
- Parasitology top 10%
-
- Ferroptosis and cancer prognosis 4
- Journals
- Nucleic Acids Research (4 papers)Angewandte Chemie International Edition (1 paper)Nature Biotechnology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Qi Liao
76 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 127
- Cancer Research 1.6k
- Molecular Biology 2.0k
- Endocrinology 81
- Aging 18
- Parasitology 58
Countries citing papers authored by Qi Liao
This map shows the geographic impact of Qi Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Liao more than expected).
Fields of papers citing papers by Qi Liao
This network shows the impact of papers produced by Qi Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Liao. The network helps show where Qi Liao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qi Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 21 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 5 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 10 | |
| 12 | 2018 | 18 | |
| 13 | 2018 | 23 | |
| 14 | 2018 | 16 | |
| 15 | 2018 | 36 | |
| 16 | 2017 | 34 | |
| 17 | 2014 | 38 | |
| 18 | 2013 | 4 | |
| 19 | 2011 | 6 | |
| 20 | Gene expression programming and K expression quick evaluate algorithm | 2007 | 1 |
About Qi Liao
Qi Liao is a scholar working on Cancer Research, Virology and Molecular Biology, having authored 77 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (31 papers), RNA modifications and cancer (21 papers), RNA Research and Splicing (13 papers), RNA and protein synthesis mechanisms (10 papers), Epigenetics and DNA Methylation (8 papers), MicroRNA in disease regulation (7 papers), Ferroptosis and cancer prognosis (4 papers) and vaccines and immunoinformatics approaches (4 papers). The work is most often cited by research in Cancer Research (1.6k citations), Molecular Biology (2.0k citations) and Endocrinology (81 citations). Qi Liao has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yi Zhao, Junming Guo, Bingxiu Xiao, Guoguang Zhao, Dechao Bu, Haitao Luo, Zhongdao Wu, Changning Liu, Yang Xi and Yongfu Shao. Their work appears in journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.